The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
Last updated
Peptide Profile

Lumbrokinase: Research, Dosing, and Where to Buy in 2026

A research-first profile for Lumbrokinase (lumbrokenise, lumbrokiness), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.

Quick Answer

Lumbrokinase is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, 2 attributed expert mentions, and 3 transcript dosing protocols for Lumbrokinase, each linked to its source.

Key Facts
Supplement
  • Also indexed as lumbrokenise, lumbrokiness.
  • 3 aggregated dosing-protocol mentions from source transcripts.
  • 8 PubMed-indexed citations listed in the research table below.
  • 0 vendor recommendations captured from named experts.
Sourced to expert
Check vendor COA
Verify dose w/ clinician

What is Lumbrokinase?

Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.

Experts on background and overview · 1 cited mention

"The serapeptase and lumbrokiness and the ntokines remove that."
Vigorous Steve · Trenbolone’s Minimum Dose, Generic GH Gone, SS-31... @ 51:52

Lumbrokinase Dosing Protocols

The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.

SpeakerSourceTimestampProtocolEvidence
Vigorous Steve / Steve Prevent Insulin Resistance On High-Dose GH, Mirabegron Vs. Clen Vs.... 01:17:40 Vigorous Steve reported a CAC-lowering protocol using 6,000 FU daily, split as 3,000 FU morning and evening. anecdotal
Vigorous Steve BAM15 Vs. ATX-304, Cagrilintide Vs. Eloralintide, SLU-PP-915,... 01:24:08 Vigorous Steve reported using 6,000 units lumbrokinase daily, combined with nattokinase and serrapeptase. anecdotal
Vigorous Steve Trenbolone’s Minimum Dose, Generic GH Gone, SS-31 Effective Dose,... 00:50:51 Stacked with nattokinase + serrapeptase, 6-8 weeks at high doses post-surgery for scar tissue anecdotal

Where to Buy Lumbrokinase in 2026

No tracked vendor recommendations for Lumbrokinase yet. See our vendor directory.

Side Effects and Safety

Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.

What Experts Say

1 expert across our source library discuss Lumbrokinase. Each entry is that expert’s most context-rich mention: click to watch it at the exact timestamp in the original video. Quotes are also emitted as Schema.org Quotation JSON-LD for AI assistants.

  1. Vigorous Steve · Trenbolone’s Minimum Dose, Generic GH Gone, SS-31...Watch @ 51:52 ↗

    “The serapeptase and lumbrokiness and the ntokines remove that.”

User Reviews

User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.

Research Efficacy Snapshot

Published efficacy percentages cited in PubMed trials and named-expert reports about Lumbrokinase. Each line links to the original source.

  • "Meta-analyses employed a random-effects model and reported odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals." · Wiyarta E et al, 2025 PubMed
  • "Compared with supportive care alone, lumbrokinase adjunct therapy significantly improved Barthel Index scores (MD = 15.17; 95% CI: 14.60 to 15.74) and reduced NIHSS scores (MD = -2.01; 95% CI: -2.06 to -1.97)." · Wiyarta E et al, 2025 PubMed
  • "Safety analyses revealed no significant increase in adverse events including gastrointestinal discomfort (OR = 1.00; 95% CI: 0.32 to 3.16) and GI bleeding (OR = 1.42; 95% CI: 0.55 to 3.67)." · Wiyarta E et al, 2025 PubMed
  • "Laboratory assessments indicated improvements in aPTT (MD = 1.93; 95% CI: 1.58 to 2.28), platelet aggregation rate (MD = -205.86; 95% CI, -206.77 to -204.96), and D-dimer levels (MD = -0.04; 95% CI: -0.05 to -0.03)." · Wiyarta E et al, 2025 PubMed

Research and Studies

8 PubMed-indexed papers reference Lumbrokinase. Top 8 shown.

Frequently Asked Questions

Is Lumbrokinase FDA-approved?

Lumbrokinase is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.

What dosing is reported for Lumbrokinase?

This page aggregates 3 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.

How much research has been published on Lumbrokinase?

8 PubMed-indexed paper(s) reference Lumbrokinase in our current research feed. See the Research and Studies section above for citations.